These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33308247)

  • 41. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoblasts/Osteocytes sirtuin6 Is Vital to Preventing Ischemic Osteonecrosis Through Targeting VDR-RANKL Signaling.
    Zhang Z; Song Y; Wang SI; Ha SH; Jang KY; Park BH; Moon YJ; Kim JR
    J Bone Miner Res; 2021 Mar; 36(3):579-590. PubMed ID: 33147653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.
    Kim JH; Kim AR; Choi YH; Kim A; Sohn Y; Woo GH; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Mar; 16(1):70. PubMed ID: 29544500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
    Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
    Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of TNF-
    Ohori F; Kitaura H; Marahleh A; Kishikawa A; Ogawa S; Qi J; Shen WR; Noguchi T; Nara Y; Mizoguchi I
    J Immunol Res; 2019; 2019():9716758. PubMed ID: 31341915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression.
    Shoji-Matsunaga A; Ono T; Hayashi M; Takayanagi H; Moriyama K; Nakashima T
    Sci Rep; 2017 Aug; 7(1):8753. PubMed ID: 28821826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alveolar Bone Protective Effect of Hiziki Extracts on the Progression of Periodontitis.
    Lee DG; Shin YK; Park JH; Park SY; Hwang E; Yang JE; Jo H; Kim KY; Mavlonov GT; Yi TH
    Mar Biotechnol (NY); 2018 Jun; 20(3):313-323. PubMed ID: 29656307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of luteolin in prevention of periodontal disease in Wistar rats.
    Balci Yuce H; Toker H; Yildirim A; Tekin MB; Gevrek F; Altunbas N
    J Periodontol; 2019 Dec; 90(12):1481-1489. PubMed ID: 31115905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis.
    Kim AR; Kim JH; Kim A; Sohn Y; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Nov; 16(1):306. PubMed ID: 30413166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of bone destruction in multiple myeloma.
    Terpos E; Christoulas D; Gavriatopoulou M; Dimopoulos MA
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28940410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells.
    Tanaka K; Yamaguchi T; Kanazawa I; Sugimoto T
    Biochem Biophys Res Commun; 2015 May; 461(2):193-9. PubMed ID: 25721666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Cinnamoyloxy-mammeisin from Geopropolis on Osteoclast Differentiation and Porphyromonas gingivalis-Induced Periodontitis.
    da Cunha MG; Ramos-Junior ES; Franchin M; Taira TM; Beutler JA; Franco GCN; Ikegaki M; de Alencar SM; Fukada SY; Rosalen PL
    J Nat Prod; 2017 Jun; 80(6):1893-1899. PubMed ID: 28570825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The neutrophil-osteogenic cell axis promotes bone destruction in periodontitis.
    Ando Y; Tsukasaki M; Huynh NC; Zang S; Yan M; Muro R; Nakamura K; Komagamine M; Komatsu N; Okamoto K; Nakano K; Okamura T; Yamaguchi A; Ishihara K; Takayanagi H
    Int J Oral Sci; 2024 Feb; 16(1):18. PubMed ID: 38413562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zanthoxylum piperitum reversed alveolar bone loss of periodontitis via regulation of bone remodeling-related factors.
    Kim MH; Lee HJ; Park JC; Hong J; Yang WM
    J Ethnopharmacol; 2017 Jan; 195():137-142. PubMed ID: 27777167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
    Wang T; Yu X; He C
    Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.